Related Experiment Video
Updated: May 15, 2026

Induction of Adhesion-dependent Signals Using Low-intensity Ultrasound
Published on: May 8, 2012
Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells
Maria Mytilinaiou1, Artan Bano, Dragana Nikitovic
1Department of Histology-Embryology, Medical School, University of Crete, Heraklion, Greece.
Abstract:
Fibrosarcoma is a rare malignant tumor originating from fibroblasts. Transforming growth factor beta 2 (TGFβ2) has been established to regulate processes correlated to fibrosarcoma tumorigenesis. In this study, we investigated the possible participation of syndecan-2 (SDC-2), a cell membrane heparan sulfate (HS) proteoglycan on these TGFβ2 functions. Our results demonstrate that the inhibition of SDC-2 expression by short interfering RNA (siSDC2) abolished TGFβ2-dependent HT1080 cell adhesion (P ≤ 0.01). In parallel, the downregulation of SDC-2 significantly inhibited TGFβ2-induced Smad2 phosphorylation (P ≤ 0.01). The immunoflourescence signal of TGF receptor III as well as its protein expression was decreased in SDC-2-deficient cells. The enhancement of adhesion molecules integrin β1 (P ≤ 0.01) and focal adhesion kinase expression, induced by TGFβ2 treatment (P ≤ 0.001), was markedly inhibited in SDC-2-defficient cells (P ≤ 0.01). Conclusively, the obtained data suggest that SDC-2 modulates TGFβ2 transcriptional regulation via Smad signaling to facilitate fibrosarcoma cell adhesion.
Insights
Syndecan-2 (SDC-2) plays a key role in fibrosarcoma tumor growth. Inhibiting SDC-2 blocks transforming growth factor beta 2 (TGFβ2) functions, including cell adhesion and signaling pathways crucial for tumor progression.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Fibrosarcoma is a rare malignant tumor derived from fibroblasts.
- Transforming growth factor beta 2 (TGFβ2) is implicated in fibrosarcoma development.
- Syndecan-2 (SDC-2), a cell membrane proteoglycan, is investigated for its role in TGFβ2 functions.
Purpose of the Study:
- To investigate the role of syndecan-2 (SDC-2) in mediating transforming growth factor beta 2 (TGFβ2) functions in fibrosarcoma.
- To elucidate the molecular mechanisms by which SDC-2 influences TGFβ2-dependent signaling pathways and cell adhesion.
Main Methods:
- Utilized short interfering RNA (siRNA) to inhibit SDC-2 expression in HT1080 fibrosarcoma cells.
- Assessed TGFβ2-dependent cell adhesion, Smad2 phosphorylation, and expression of TGF receptor III, integrin β1, and focal adhesion kinase.
- Employed immunofluorescence and Western blot techniques to analyze protein expression and localization.
Main Results:
- SDC-2 inhibition abolished TGFβ2-dependent HT1080 cell adhesion.
- Downregulation of SDC-2 significantly inhibited TGFβ2-induced Smad2 phosphorylation.
- Reduced expression of TGF receptor III, integrin β1, and focal adhesion kinase was observed in SDC-2-deficient cells.
Conclusions:
- SDC-2 modulates TGFβ2 transcriptional regulation through Smad signaling.
- SDC-2 facilitates fibrosarcoma cell adhesion, suggesting it as a potential therapeutic target.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Regulation of Angiogenesis and Blood Supply
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Overview of Cell-Matrix Interactions

